POLR3E
Basic information
Region (hg38): 16:22297375-22335101
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLR3E gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 55 | 60 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 55 | 5 | 1 |
Variants in POLR3E
This is a list of pathogenic ClinVar variants found in the POLR3E region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-22305171-G-T | not specified | Uncertain significance (May 05, 2023) | ||
16-22308178-G-C | Uncertain significance (Jun 10, 2022) | |||
16-22308190-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
16-22308197-C-T | not specified | Uncertain significance (Mar 31, 2022) | ||
16-22308965-A-G | not specified | Uncertain significance (Oct 27, 2023) | ||
16-22308971-G-A | not specified | Uncertain significance (Oct 11, 2024) | ||
16-22308975-C-A | not specified | Uncertain significance (Aug 28, 2021) | ||
16-22308992-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
16-22309025-C-T | not specified | Uncertain significance (Apr 26, 2024) | ||
16-22309469-C-T | not specified | Uncertain significance (Dec 31, 2023) | ||
16-22309492-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
16-22309505-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
16-22313625-C-T | not specified | Uncertain significance (May 24, 2023) | ||
16-22313631-C-G | not specified | Uncertain significance (Dec 04, 2024) | ||
16-22313650-T-C | not specified | Uncertain significance (May 30, 2022) | ||
16-22313704-G-A | not specified | Uncertain significance (Sep 27, 2022) | ||
16-22313723-C-T | Likely benign (Apr 01, 2022) | |||
16-22315105-C-T | not specified | Uncertain significance (Oct 26, 2024) | ||
16-22315123-G-A | not specified | Uncertain significance (Jun 25, 2024) | ||
16-22315138-A-G | not specified | Uncertain significance (Oct 20, 2023) | ||
16-22315185-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
16-22316623-G-A | not specified | Uncertain significance (Jul 31, 2024) | ||
16-22316652-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
16-22316667-G-A | not specified | Uncertain significance (May 04, 2022) | ||
16-22317029-G-A | not specified | Uncertain significance (Jun 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POLR3E | protein_coding | protein_coding | ENST00000299853 | 20 | 37695 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0132 | 0.987 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.54 | 364 | 457 | 0.797 | 0.0000304 | 4633 |
Missense in Polyphen | 62 | 98.89 | 0.62696 | 985 | ||
Synonymous | -1.84 | 230 | 197 | 1.17 | 0.0000143 | 1364 |
Loss of Function | 4.37 | 12 | 42.9 | 0.280 | 0.00000217 | 466 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000626 | 0.0000626 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000232 | 0.000231 |
European (Non-Finnish) | 0.0000726 | 0.0000703 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs. Essential for efficient transcription from both the type 2 VAI and type 3 U6 RNA polymerase III promoters. Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs) induce type I interferon and NF- Kappa-B through the RIG-I pathway (By similarity). {ECO:0000250, ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Cytosolic DNA-sensing pathway - Homo sapiens (human);RNA polymerase - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Pyrimidine metabolism;Eukaryotic Transcription Initiation;Gene expression (Transcription);Purine metabolism;Pyrimidine metabolism;RNA Polymerase III Transcription Termination;RNA Polymerase III Chain Elongation;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription
(Consensus)
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- loftool
- 0.544
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 15.32
Haploinsufficiency Scores
- pHI
- 0.352
- hipred
- Y
- hipred_score
- 0.602
- ghis
- 0.596
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.996
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Polr3e
- Phenotype
Gene ontology
- Biological process
- transcription by RNA polymerase III;innate immune response;defense response to virus
- Cellular component
- nucleus;nucleoplasm;RNA polymerase III complex;cytosol
- Molecular function
- RNA polymerase III activity